Impact of HCV cure on systemic inflammation and bone density, quality, and turnover
BackgroundChronic hepatitis C virus (HCV) infection has been associated with osteoporosis and fragility fracture, which may be mediated by increased systemic inflammation, especially in HIV-HCV co-infection. Treatment with direct-acting antivirals (DAA…